[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO1990004967A3 - Pommade topique - Google Patents

Pommade topique Download PDF

Info

Publication number
WO1990004967A3
WO1990004967A3 PCT/EP1989/001276 EP8901276W WO9004967A3 WO 1990004967 A3 WO1990004967 A3 WO 1990004967A3 EP 8901276 W EP8901276 W EP 8901276W WO 9004967 A3 WO9004967 A3 WO 9004967A3
Authority
WO
WIPO (PCT)
Prior art keywords
ointment
oil
topical ointment
spermaceti
efficacity
Prior art date
Application number
PCT/EP1989/001276
Other languages
German (de)
English (en)
Other versions
WO1990004967A2 (fr
Inventor
Gabriele Flender
Original Assignee
Weck Wolfgang
Gabriele Flender
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weck Wolfgang, Gabriele Flender filed Critical Weck Wolfgang
Priority to JP1511363A priority Critical patent/JPH0647544B2/ja
Publication of WO1990004967A2 publication Critical patent/WO1990004967A2/fr
Publication of WO1990004967A3 publication Critical patent/WO1990004967A3/fr
Priority to DK007191A priority patent/DK7191A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Une pommade topique pour le traitement localisé de dermatoses, en particulier du psoriasis, contient entre 10 et 50 % en poids de vaseline, entre 10 et 50 % en poids d'huile de jujube, entre 1 et 10 % en poids de cholestérine, entre 1 et 10 % en poids de cire d'abeille ou de cétine ou de succédané de cétine, et enfin entre 10 et 40 % en poids d'eau. L'efficacité remarquable de cette pommmade est due avant tout aux vertus pharmaceutiques de la cholestérine qui entre dans sa composition. Ladite pommade est en outre particulièrement bien supportée par les peaux sensibles et à tendance allergique.
PCT/EP1989/001276 1988-10-31 1989-10-26 Pommade topique WO1990004967A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP1511363A JPH0647544B2 (ja) 1988-10-31 1989-10-26 乾癬の局所治療薬
DK007191A DK7191A (da) 1988-10-31 1991-01-15 Topisk salve

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3836971.0 1988-10-31
DE3836971A DE3836971C1 (fr) 1988-10-31 1988-10-31

Publications (2)

Publication Number Publication Date
WO1990004967A2 WO1990004967A2 (fr) 1990-05-17
WO1990004967A3 true WO1990004967A3 (fr) 1990-06-28

Family

ID=6366210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1989/001276 WO1990004967A2 (fr) 1988-10-31 1989-10-26 Pommade topique

Country Status (11)

Country Link
US (1) US5179086A (fr)
EP (2) EP0367103B1 (fr)
JP (1) JPH0647544B2 (fr)
AT (1) ATE84216T1 (fr)
CA (1) CA2001797A1 (fr)
DE (2) DE3836971C1 (fr)
DK (1) DK7191A (fr)
ES (1) ES2053907T3 (fr)
GR (1) GR3007370T3 (fr)
PT (1) PT92148B (fr)
WO (1) WO1990004967A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705030A1 (fr) * 1993-05-11 1994-11-18 Biodev Utilisation de composés stéroliques pour la fabrication d'un médicament anti-inflammatoire.
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US5444092A (en) * 1994-07-20 1995-08-22 Collins; Jerry Method and composition for treating psoriasis
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
EP1958961A3 (fr) * 1998-11-13 2008-09-03 Cyclacel Limited Vecteurs de transport
ATE361082T1 (de) 1999-02-01 2007-05-15 Dermal Res Lab Inc Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
TNSN02063A1 (en) * 2001-07-07 2005-12-23 Egyptian Natural Oil Co Natoil The medical effect of jojoba oil
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
US20050002884A1 (en) * 2003-07-02 2005-01-06 Marsella Jefferson Hair treatment compositions
US7374754B2 (en) * 2003-09-02 2008-05-20 Essential Skincare, Llc Use of placental alkaline phosphatase to promote skin cell proliferation
US8455016B2 (en) * 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
EP1965830B1 (fr) * 2005-12-28 2014-05-14 Zoltan Laboratories Llc Utilisation de phosphatase alcaline pour le maintien de la masse de tissus sains chez des mammiferes
WO2010074172A1 (fr) * 2008-12-24 2010-07-01 株式会社バイオメッドコア Procédé de fabrication d'un liposome et procédé de dissolution de cholestérol
WO2011136288A1 (fr) 2010-04-28 2011-11-03 久光製薬株式会社 Préparation contenant du donépézil absorbable par voie transdermique
CN102858372A (zh) 2010-04-28 2013-01-02 久光制药株式会社 皮肤刺激抑制剂和经皮吸收制剂
EP2772252B1 (fr) 2011-10-26 2020-03-18 Hisamitsu Pharmaceutical Co., Inc. Préparation à absorption transdermique comprenant une oxybutynine
US9717741B2 (en) 2012-10-11 2017-08-01 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
US9987361B1 (en) 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
GB201814036D0 (en) 2018-08-29 2018-10-10 Ucl Business Plc New therapy
US20210393724A1 (en) * 2018-11-01 2021-12-23 Yeditepe Universitesi Medicine for treatment of psoriasis and production method thereof
GB201918752D0 (en) * 2019-12-18 2020-01-29 Ucl Business Plc New therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098568A2 (fr) * 1982-07-07 1984-01-18 Schering Aktiengesellschaft Préparations pour l'application topique contenant des corticoides
DE3526669A1 (de) * 1984-07-26 1986-02-06 Oreal Neues emulsionssystem auf basis eines erdalkali- oder metallischen lanolates und emulsionen des wasser-in-oel-typs auf basis dieses emulsionssystems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE523144C (de) * 1927-09-11 1931-04-20 Friedrich Passek Verfahren zur Herstellung wasserreicher Cholesterinloesungen
DE638839C (de) * 1935-01-15 1936-11-24 Chem Fab Promonta G M B H Verfahren zur Herstellung waessrig-alkoholischer Cholesterinloesungen
FR928337A (fr) * 1946-05-20 1947-11-25 Procédé d'obtention de solutions stables de cholestérine, en vue de la préparation de produits cosmétiques et de beauté
FR2485921A1 (fr) * 1980-07-01 1982-01-08 Oreal Composition cosmetique a base d'une dispersion aqueuse de spherules lipidiques
IT8221553A0 (it) * 1982-05-28 1982-05-28 Gruppo Scient Revici Pacelli Composizioni farmaceutiche adattivita' antineoplastica.
US4743597A (en) * 1986-01-27 1988-05-10 Javitt Norman B Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
FR2597346B1 (fr) * 1986-04-22 1989-08-18 Oreal Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098568A2 (fr) * 1982-07-07 1984-01-18 Schering Aktiengesellschaft Préparations pour l'application topique contenant des corticoides
DE3526669A1 (de) * 1984-07-26 1986-02-06 Oreal Neues emulsionssystem auf basis eines erdalkali- oder metallischen lanolates und emulsionen des wasser-in-oel-typs auf basis dieses emulsionssystems

Also Published As

Publication number Publication date
PT92148B (pt) 1995-06-30
PT92148A (pt) 1990-05-31
ES2053907T3 (es) 1994-08-01
GR3007370T3 (fr) 1993-07-30
ATE84216T1 (de) 1993-01-15
CA2001797A1 (fr) 1990-04-30
EP0367103A1 (fr) 1990-05-09
JPH04501415A (ja) 1992-03-12
DK7191D0 (da) 1991-01-15
DK7191A (da) 1991-06-04
JPH0647544B2 (ja) 1994-06-22
EP0367103B1 (fr) 1993-01-07
EP0440715A1 (fr) 1991-08-14
US5179086A (en) 1993-01-12
DE58903222D1 (de) 1993-02-18
WO1990004967A2 (fr) 1990-05-17
DE3836971C1 (fr) 1990-05-17

Similar Documents

Publication Publication Date Title
WO1990004967A3 (fr) Pommade topique
US4512978A (en) Dermatological composition useful in the treatment of psoriasis
AU4605693A (en) Photoprotection compositions comprising tocopherol sorbate and anti-inflammatory agent
EP0313347A3 (fr) Compositions photoprotectrices contenant de l'acide sorbohydroxamique et un agent anti-inflammatoire
IE831611L (en) Topical anti-inflammatory compositions
EP0336880A3 (fr) Utilisation de préparations applicables topiquement pour le traitement du vieillissement de la peau
AU5457390A (en) Photoprotection compositions comprising sorbohydroxamic acid
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
EP0297733A3 (fr) Médicaments contenant des butanes catécholiques
AU598020B2 (en) Cosmetic composition
AU690377B2 (en) Application of superoxide dismutase in liposomes
AU2408388A (en) Photoprotection compositions comprising tocopherol sorbate
EP0249736A3 (fr) Onguent pour le traitement des maladies de peau
AU2726692A (en) Penetration enhancement of topically applied formulations
NO171095C (no) Fremgangsmaate for fremstilling av en topisk antibakteriell salve
AU674142B2 (en) Use of cosmetic composition
AU7233787A (en) Novel topical metronidazole formulations and therapeutic uses thereof
AU5916990A (en) Preparations for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
SE9801647D0 (sv) Therapeutic composition
EP0801945A3 (fr) Utilisation de glucosides de l'acide férilique comme actifs contre l'irritation dans des compositions cosmétiques ou topiques dermatologiques
DE3867560D1 (de) Verwendung von azidothymidin zur behandlung der psoriasis.
CA2061870A1 (fr) Compositions medicinales utilisees comme cremes hydratantes et dans le traitement de l'eczema
DE2729010C2 (de) Arzneimittel zur Behandlung der Cellulite und des Fettübergewichtes
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
JP2640492B2 (ja) 皮膚外用剤

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): DK JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): DK JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1989912240

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989912240

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1989912240

Country of ref document: EP